Literature DB >> 32885362

Clinical Success and Correlation of Eckardt Scores with Barium Esophagram After Peroral Endoscopic Myotomy in Achalasia.

Madhusudan R Sanaka1, Pravallika Chadalavada2, Fahrettin Covut2, George Khoudari2, Scott Gabbard3, Prashanthi N Thota3, Siva Raja4.   

Abstract

Entities:  

Keywords:  Achalasia; Eckardt score; Myotomy; Peroral endoscopic myotomy (POEM); Timed barium esophagram

Mesh：

Substances：

Year:  2020        PMID： 32885362     DOI： 10.1007/s11605-020-04763-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  3 in total

1.  Clinical outcomes five years after POEM for treatment of primary esophageal motility disorders.

Authors:  Ezra N Teitelbaum; Christy M Dunst; Kevin M Reavis; Ahmed M Sharata; Marc A Ward; Steven R DeMeester; Lee L Swanström
Journal:  Surg Endosc       Date:  2017-06-29       Impact factor: 4.584

2.  Long-Term Efficacy of Peroral Endoscopic Myotomy for Patients with Achalasia: Outcomes with a Median Follow-Up of 36 Months.

Authors:  Chenghai He; Meng Li; Bin Lu; Xiao Ying; Chen Gao; Shuangshuang Wang; Chengao Ma; Chaoqiong Jin
Journal:  Dig Dis Sci       Date:  2018-11-26       Impact factor: 3.199

3.  Endoscopic or Surgical Myotomy in Patients with Idiopathic Achalasia.

Authors:  Yuki B Werner; Bengt Hakanson; Jan Martinek; Alessandro Repici; Burkhard H A von Rahden; Albert J Bredenoord; Raf Bisschops; Helmut Messmann; Marius C Vollberg; Tania Noder; Jan F Kersten; Oliver Mann; Jakob Izbicki; Alexander Pazdro; Uberto Fumagalli; Riccardo Rosati; Christoph-Thomas Germer; Marlies P Schijven; Alice Emmermann; Daniel von Renteln; Paul Fockens; Guy Boeckxstaens; Thomas Rösch
Journal:  N Engl J Med       Date:  2019-12-05       Impact factor: 91.245
  3 in total
  1 in total

1.  Development of a Deep Learning System to Detect Esophageal Cancer by Barium Esophagram.

Authors:  Peipei Zhang; Yifei She; Junfeng Gao; Zhaoyan Feng; Qinghai Tan; Xiangde Min; Shengzhou Xu
Journal:  Front Oncol       Date:  2022-06-21       Impact factor: 5.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.